Istradefylline for Parkinson Disease With Cognitive Impairment

Clinical trial NCT05333549 · COMPLETED

Trial details

NCT number: NCT05333549
Sponsor: Virginia Commonwealth University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Cognitive Impairment

Start date: 2022-07-18
Primary completion: 2025-06-09
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.